← back to search

Jennifer Loveless

Houston Methodist · US
Area of research
Emergency Medicine · Infectious Diseases
Research interest
Research focused on Guideline and Pediatric Infectious Disease, with related work in Intensive care medicine, Histoplasmosis, Appendicitis. Notable publications include '2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Risk Assessment, Diagnostic Imaging, and...', '2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Diagnostic Imaging of Suspected Acute Appendicitis...', and '2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules (Histoplasmomas)...'.
h-index
citations
88
works
4
NIH funding
primary concept
email

Recent publications

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic <i>Histoplasma</i> Pulmonary Nodules (Histoplasmomas) and Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant People
Clinical Infectious Diseases 2025cited by 15position: lastdoi
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Risk Assessment, Diagnostic Imaging, and Microbiological Evaluation in Adults, Children, and Pregnant People
Clinical Infectious Diseases 2024cited by 41position: lastdoi
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Diagnostic Imaging of Suspected Acute Appendicitis in Adults, Children, and Pregnant People
Clinical Infectious Diseases 2024cited by 19position: lastdoi
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis
Clinical Infectious Diseases 2024cited by 13position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Robert A. Bonomo · Louis Stokes Cleveland VA Medical Center2 papers (2024–2024)Keith S. Kaye · Rutgers, The State University of New Jersey2 papers (2024–2024)David R. Snydman · Tufts University2 papers (2024–2024)Katelyn Donnelly · University of Illinois Chicago2 papers (2024–2024)Romney M. Humphries · Vanderbilt University Medical Center2 papers (2024–2024)Pranita D. Tamma · Johns Hopkins University2 papers (2024–2024)E. Patchen Dellinger · University of Washington2 papers (2024–2024)Brian A. Potoski · University of Pittsburgh2 papers (2024–2024)Marion Skalweit · Case Western Reserve University2 papers (2024–2024)Mary Bessesen · University of Colorado Denver2 papers (2024–2024)Fredrick M. Abrahamian · University of California, Los Angeles2 papers (2024–2024)Mary K. Hayden · Rush University Medical Center2 papers (2024–2024)Ellie J. C. Goldstein · IBM Research - Almaden2 papers (2024–2024)Jesús Rodríguez‐Baño · Instituto de Salud Carlos III2 papers (2024–2024)Robert G. Sawyer · Virginia Commonwealth University2 papers (2024–2024)Anthony W. Chow · Strong Memorial Hospital2 papers (2024–2024)Morven S. Edwards · Baylor College of Medicine2 papers (2024–2024)Satish Mocherla · Houston Methodist1 papers (2025–2025)Roger Bedimo · VA North Texas Health Care System1 papers (2024–2024)Sarah Pahlke · George Washington University1 papers (2024–2024)